Related Experiment Video
Updated: Apr 2, 2026

10:48
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
10.2K
Radiotherapy after hyperbaric oxygenation in malignant gliomas.
Jun-rui Chen1, Hong-zhi Xu1, Jian-bo Ding1
1a Department of Neurosurgery , Huashan Hospital, Shanghai Medical College, Fudan University , Shanghai , China.
Current Medical Research and Opinion
|September 29, 2015
Summary
Adding hyperbaric oxygen (HBO) therapy before radiation therapy (RT) appears safe and may improve outcomes for high-grade glioma patients. This combination therapy showed enhanced survival and progression-free survival with minimal added toxicity.
Area of Science:
- Neuro-oncology
- Radiation Oncology
- Hyperbaric Medicine
Background:
- High-grade gliomas are aggressive brain tumors with limited treatment options.
- Radiation therapy (RT) is a standard treatment, but outcomes remain poor.
- Investigating novel therapeutic combinations is crucial for improving patient survival.
Purpose of the Study:
- To evaluate the efficacy and toxicity of combining hyperbaric oxygen (HBO) therapy with radiation therapy (RT) for high-grade gliomas.
- To synthesize findings from prospective studies on HBO followed by RT in glioma patients.
Main Methods:
- Systematic review of PubMed, Embase, ISI Web of Knowledge, and Cochrane databases.
- Search terms included radiotherapy, hyperbaric oxygenation, chemotherapy, glioma, and brain tumor.
- Analysis focused on prospective studies of HBO followed by RT for high-grade gliomas, extracting data on patient characteristics, treatment protocols, and outcomes.
Main Results:
- Eight studies involving 227 patients (142 with grade IV, 61 with grade III gliomas) were analyzed.
- Combined HBO and RT therapy demonstrated improved outcomes, including survival rate and progression-free survival.
- Toxicity was generally manageable, with only one case of severe HBO-related complication (middle ear barotrauma).
Conclusions:
- The addition of HBO to RT is well-tolerated in patients with high-grade gliomas.
- This combined treatment approach shows potential benefit for improving patient outcomes.
- Further research may solidify HBO plus RT as a valuable therapeutic strategy for gliomas.

